Ewa Cendrowicz - Univ Groningen, Univ Med Ctr Groningen UMCG

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 19 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Table S5 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-Gcb) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra,Yejun He, Janneke de Boer, H.S. Kooistra,Ewa Cendrowicz,Rudolf S.N. Fehrmann,Emanuele Ammatuna,Christine zu Eulenburg,Marcel Nijland, Gerwin Huls, Edwin Bremer,Tom van Meerten

openalex（2023）

引用0浏览0引用

Population Pharmacokinetic-Pharmacodynamic Model of Nirogacestat Effects on B-cell Maturation Antigen in Healthy Subjects

Todd Shearer, Rex L. Williams, Mark Johnson,Ewa Cendrowicz,Cathrine Leonowens,Margaret Smith, Todd Baughman, Caroline J. Breitbach,L. Mary Smith,Shinta Cheng

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

Table S5 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-Gcb) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra,Yejun He, Janneke de Boer, H.S. Kooistra,Ewa Cendrowicz,Rudolf S.N. Fehrmann,Emanuele Ammatuna,Christine zu Eulenburg,Marcel Nijland, Gerwin Huls, Edwin Bremer,Tom van Meerten

openalex（2023）

引用0浏览0引用

Figure S1, S2, S3, S4 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-Gcb) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra,Yejun He, Janneke de Boer, H.S. Kooistra,Ewa Cendrowicz,Rudolf S.N. Fehrmann,Emanuele Ammatuna,Christine zu Eulenburg,Marcel Nijland, Gerwin Huls, Edwin Bremer,Tom van Meerten

openalex（2023）

引用0浏览0引用

Table S4 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-Gcb) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra,Yuan He, Janneke de Boer,Hilde Kooistra,Ewa Cendrowicz,Rudolf S.N. Fehrmann,Emanuele Ammatuna,Christine zu Eulenburg,Marcel Nijland, Gerwin Huls, Edwin Bremer,Tom van Meerten

openalex（2023）

引用0浏览0引用

Figure S1, S2, S3, S4 from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-Gcb) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra,Yejun He, Janneke de Boer, H.S. Kooistra,Ewa Cendrowicz,Rudolf S.N. Fehrmann,Emanuele Ammatuna,Christine zu Eulenburg,Marcel Nijland, Gerwin Huls, Edwin Bremer,Tom van Meerten

openalex（2023）

引用0浏览0引用

Supplementary Figure Legends from CD47 Expression Defines Efficacy of Rituximab with CHOP in Non–Germinal Center B-cell (Non-Gcb) Diffuse Large B-cell Lymphoma Patients (DLBCL), but Not in GCB DLBCL

Renée Bouwstra,Yejun He, Janneke de Boer, H.S. Kooistra,Ewa Cendrowicz,Rudolf S.N. Fehrmann,Emanuele Ammatuna,Christine zu Eulenburg,Marcel Nijland, Gerwin Huls, Edwin Bremer,Tom van Meerten

openalex（2023）

引用0浏览0引用

CD24 is a Potential Immunotherapeutic Target for Mantle Cell Lymphoma

Jimena Alvarez Freile,Natasha Ustyanovska Avtenyuk,Macarena Gonzalez Corrales,Harm Jan Lourens,Gerwin Huls,Tom van Meerten,Ewa Cendrowicz,Edwin Bremer

Biomedicinesno. 5 (2022): 1175-1175

引用11浏览0WOS引用

Tumor Microenvironment of Hepatocellular Carcinoma: Challenges and Opportunities for New Treatment Options

Zuzanna Sas,Ewa Cendrowicz,Isabel Weinhäuser,Tomasz P Rygiel

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES（2022）

引用35浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn